Fosaprepitant and Decitabine generics receive FDA approval
Generic treatments for blood/bone marrow disorders and acute nausea and vomiting associated with chemotherapy have gained FDA approval.
List view / Grid view
News
EMA to review Picato after rise in skin cancer cases
The EMA will assess the marketing authorisation for the medication to see whether it is a cause of skin cancer in patients.
EC approves expanded use of ustekinumab for ulcerative colitis
The biologic treatment ustekinumab has been granted an expanded use for ulcerative colitis within the EU.
Korean pharma company alleged to have conducted trials on employees
Ahngook Pharmaceuticals reportedly held clinical trials on its employees without their consent, leading to the arrest of the company president.
Respiratory virus vaccine receives breakthrough therapy designation
The FDA has awarded a breakthrough therapy designation to an investigational prophylactic vaccine to treat respiratory syncytial virus in seniors.
Purdue Pharma prepares for bankruptcy ahead of opioid crisis trial
A report has found that the rejection of a settlement offer from Purdue has led to the company arranging to file for bankruptcy.
China grants Tagrisso (osimertinib) marketing authorisation
Following positive clinical trials, the Tagrisso drug has been given marketing authorisation in China for treatment of NSCLC.
Drug delivery improved through mesoporous materials
A new study on DOX as a model drug has potential applications in the drug delivery field for better control drug release.
Pharma reputation worst among other industries in US
An annual report has found that the pharmaceutical sector is the lowest regarded industry among US citizens.
Pakistan lifts Indian import ban for essential medications
A ban on Indian trade to Pakistan has been partly changed to allow the import of drugs after a shortage of critical medicine.
Brain disease drug delivery platform developed by researchers
So-called 'nanodiamonds' could serve as a platform for diagnostic and therapeutic approaches for neurodegenerative diseases.
NICE recommends voretigene neparvovec for use on NHS
The voretigene neparvovec gene therapy treatment has been highlighted in draft guidance by NICE for availability on the NHS.
Sandoz issues voluntary recall for medication bottles
The pharmaceutical company has announced a recall for certain prescription drug bottles which do not meet child-resistant regulations.
China’s drug bulk-buy programme has been expanded
China has expanded a pilot drug bulk-buying programme to almost the entire country which is adding pressure on pharma companies.
Endo and Allergan settle opioid case ahead of trial
The two pharma companies have agreed to pay $15 million to certain Ohio counties before an opioid abuse trial to be held in October.
